In the United States, the rate for anal cancer in the general population is 1 case per 100,000 people; among HIV-negative men who have sex with men the rate increases to 35 cases per 100,000 people. For HIV-positive gay and bisexual men, the rate is estimated to be between 75 to 115 cases per 100,000 […]
Everything You Need to Know About Anal Cancer Prevention and Treatment Read More »
Nelson Vergel from PowerUSA.org interviews Dr Steven Grinspoon from Harvard Medical School about what we know about HIV lipodystrophy associated fat accumulation. Dr Grinspoon covers potential causes and treatments. For more information please refer to the closing image at the end of the video. QUESTIONS FOR DR GRINSPOON’S INTERVIEW: 1. Please give our audience background
Abdominal Fat Accumulation in HIV: Interview with Dr Grinspoon Read More »
Cristobal Plaza, director of ActionforSolidarity.org, talks about the medication shortages in Venezuela and how you can help while the situation is resolved one day. Action for Solidarity is a United States established and active 501 (c) (3) Non-profit Organization. We will ensure that your donation will get to the people who need these medicines by using the extensive distribution network
Be a Hero- Send Your Unused Medications to Venezuelans in Crisis Read More »
Nelson Vergel from the non-profit Program for Wellness Restoration ( www.PoWeRUSA.org ) interviews Dr Luis Casavantes about his experience with PMMA filler for HIV-related facial/buttock wasting reconstruction. He also shares his experience on the use of PMMA for penile girth enlargement. For more info visit www.AvantiDerma.com. You can also find more info on PoWeR’s site
Interview with Dr Luis Casavantes About Facial, Buttock and Penile Fillers Read More »
Nelson Vergel, director of Program for Wellness Restoration, interviews Dr Pierone about his long experience treating patients with HIV facial lipoatrophy and his upcoming study for patients with HIV related abdominal fat accumulation. His website is www.FacialRejuvenationFL.com You can also ask him questions on TheBody.com. You can also find more info on PoWeR’s site www.FacialWasting.org
Interview with Dr Gerald Pierone About HIV Lipodystrophy Options Read More »
Estimated median survival in the HIV group rose from 11.8 years in 1996-1999 to 17.8 years in 2000-2005 and to 22.5 years in 2006-2014. Median survival in general population controls was 30.2 years across all three periods. Mortality rate ratio comparing HIV-positive people with controls was highest among 50- to 55-year-olds (3.8) and declined in
Life Expectancy Rising in HIV Group Over 50, But Still Lags General Population Read More »
One of the surprises at CROI 2016 was the first virological data from a new highly potent NRTI that in a slow-release formulation has the potential for annual dosing and that is undergoing research as both treatment and PrEP. In an oral late-breaker, Jay Grobler from Merck presented results from a dose-ranging study in macaques
New HIV Drug Has Potential for Weekly or Once-Yearly Dosing Read More »
CROI 2016 Conference Abstract Number: 795 Safety of Tenofovir Alafenamide in Renal Impairment Author(s): Anton Pozniak2, Jose R Arribas3, Samir K. Gupta4, Frank A. Post5, Anchalee Avihingsanon6, Gordon Crofoot7, Kenneth A. Lichtenstein8, Moti Ramgopal9, Ploenchan Chetchotisakd10, Marshall W. Fordyce11 Clinical Research, Gilead Sciences Inc, Foster City, CA, United States. 2 Chelsea and Westminster Hospital NHS Foundation Trust, London,
Switching HIV+ Patients From Stribld to Genvoya Improved Proteinuria but Not eGFR Read More »
HIV can defeat efforts to cripple it with CRISPR gene-editing technology, researchers say. And the very act of editing — involving snipping at the virus’s genome — may introduce mutations that help it to resist attack. At least half a dozen papers over the past three years have explored using the popular CRISPR–Cas9 gene editing
HIV Mutates Around Promising Gene Editing Technology (CRISPR-CAS 9) Read More »
HIV-related wasting can have long-term consequences People who suffered wasting in the past more vulnerable to frailty in later life Michael Carter Published: 30 November 2015 HIV-associated wasting can have a long-term impact on physical function and quality of life, according to research from the United States published in the online edition of AIDS. The research
HIV-related wasting can have long-term consequences Read More »
Men who have anal sex with men (MSM) are more likely to get anal HPVthan men who only have sex with women. Researchers estimate that the prevalence of anal HPV among men who only have sex with women is around 15% while anal HPV prevalence for MSM is around 60%. If you add HIV into the mix, infection risk
HPV and HIV: What You Need to Know About Anal Cancer (Video) Read More »
Forum on Aging With HIV: H. Pylori and HIV: What Do I Need to Know? (Editor’s Pick) Forum on Aging With HIV: H. Pylori and HIV: What Do I … I am very familiar with H. Pylori. I was diagnosed with it using a urea breath test 2
Best Posts on Aging with HIV from TheBody.com This Week Read More »
